Compare TCBK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBK | NNNN |
|---|---|---|
| Founded | 1975 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 1995 | N/A |
| Metric | TCBK | NNNN |
|---|---|---|
| Price | $47.11 | $22.77 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $53.80 | N/A |
| AVG Volume (30 Days) | ★ 140.5K | 39.6K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | ★ 6.94 | N/A |
| EPS | ★ 3.70 | N/A |
| Revenue | ★ $53,445,000.00 | N/A |
| Revenue This Year | $11.70 | N/A |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | ★ $13.04 | $446.57 |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $35.20 | $5.91 |
| 52 Week High | $53.18 | $55.65 |
| Indicator | TCBK | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | 44.41 |
| Support Level | $46.76 | $22.08 |
| Resistance Level | $51.11 | $31.44 |
| Average True Range (ATR) | 1.44 | 2.46 |
| MACD | -0.32 | -0.09 |
| Stochastic Oscillator | 18.47 | 16.81 |
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.